CORRAL; Laura

Patent Applications and Registrations

Patent applications and USPTO patent grants for CORRAL; Laura.The latest application filed is for "methods for determining drug efficacy using cereblon-associated proteins".

Company Profile

1.10.20

CORRAL; Laura - La Jolla CA
CORRAL; Laura - San Francisco CA
Corral; Laura - Jamaica Plain MA
Corral; Laura - Belmont MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods For Determining Drug Efficacy Using Cereblon-associated Proteins App 20180209961 - SCHAFER; Peter H. ; et al.	2018-07-26
Methods for determining drug efficacy using cereblon-associated proteins Grant 9,857,359 - Schafer , et al. January 2, 2	2018-01-02
Lipoprotein-associated Phospholipase A2 Antibody Compositions And Methods Of Use App 20150203590 - MILLER; Paul Levi ; et al.	2015-07-23
Lipoprotein-associated phospholipase A2 antibody compositions and methods of use Grant 9,000,132 - Miller , et al. April 7, 2	2015-04-07
Lipoprotein-associated Phospholipase A2 Antibody Compositions And Methods Of Use App 20140283157 - Miller; Paul Levi ; et al.	2014-09-18
Lipoprotein-associated Phospholipase A2 Antibody Compositions And Methods Of Use App 20140275485 - MILLER; Paul Levi ; et al.	2014-09-18
Methods For Determining Drug Efficacy Using Cereblon-associated Proteins App 20140162282 - SCHAFER; Peter H. ; et al.	2014-06-12
Phosphorylated RaIA Grant 8,637,260 - Hahn , et al. January 28, 2	2014-01-28
Ovr115 Antibody Compositions And Methods Of Use App 20130022539 - Pilkington; Glenn ; et al.	2013-01-24
Pro108 Antibody Compositions and Methods of Use and Use of Pro108 to Assess Cancer Risk App 20120329079 - Simon; Iris ; et al.	2012-12-27
Pro104 Antibody Compositions and Methods of Use App 20120263647 - Papkoff; Jackie ; et al.	2012-10-18
Ovr115 antibody compositions and methods of use Grant 8,207,311 - Pilkington , et al. June 26, 2	2012-06-26
Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk Grant 8,148,093 - Simon , et al. April 3, 2	2012-04-03
Pro104 antibody compositions and methods of use Grant 8,080,650 - Papkoff , et al. December 20, 2	2011-12-20
Phosphorylated RalA App 20110306057 - Hahn; William C. ; et al.	2011-12-15
OVR110 Antibody Compositions and Methods of Use App 20100209438 - Pilkington; Glenn ; et al.	2010-08-19
Ovr110 antibody compositions and methods of use Grant 7,619,068 - Pilkington , et al. November 17, 2	2009-11-17
PRO108 Antibody Compositions and Methods of Use and Use of PRO108 to Assess Cancer Risk App 20090232732 - SIMON; IRIS ; et al.	2009-09-17
Pro104 Antibody Compositions and Methods of Use App 20090220424 - Papkoff; Jackie ; et al.	2009-09-03
Ovr110 Antibody Compositions And Methods For Use App 20090136490 - Pilkington; Glenn ; et al.	2009-05-28
Pro104 antibody compositions and methods of use Grant 7,479,546 - Papkoff , et al. January 20, 2	2009-01-20
Methods and compositions using immunomodulatory compounds in combination therapy App 20080051431 - Verhelle; Dominique ; et al.	2008-02-28
Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk Grant 7,294,704 - Simon , et al. November 13, 2	2007-11-13
Ovr110 antibody compositions and methods of use App 20070178101 - Pilkington; Glenn ; et al.	2007-08-02
Ovr115 antibody compositions and methods of use App 20070104647 - Pilkington; Glenn ; et al.	2007-05-10
Pro104 antibody compositions and methods of use App 20070087004 - Papkoff; Jackie ; et al.	2007-04-19
Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk App 20050124012 - Simon, Iris ; et al.	2005-06-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.